Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.12
-0.17 (-1.28%)
At close: Mar 9, 2026, 4:00 PM EDT
13.12
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:30 PM EDT
Avanos Medical Revenue
In the year 2025, Avanos Medical had annual revenue of $701.20M with 1.95% growth. Avanos Medical had revenue of $180.90M in the quarter ending December 31, 2025, with 0.72% growth.
Revenue (ttm)
$701.20M
Revenue Growth
+1.95%
P/S Ratio
0.87
Revenue / Employee
$306,603
Employees
2,287
Market Cap
610.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 701.20M | 13.40M | 1.95% |
| Dec 31, 2024 | 687.80M | 14.50M | 2.15% |
| Dec 31, 2023 | 673.30M | -10.80M | -1.58% |
| Dec 31, 2022 | 684.10M | 97.10M | 16.54% |
| Dec 31, 2021 | 587.00M | -127.80M | -17.88% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Integra LifeSciences Holdings | 1.64B |
| Varex Imaging | 854.40M |
| Orthofix Medical | 822.31M |
| Bioventus | 568.09M |
| Tactile Systems Technology | 329.52M |
| Cytek Biosciences | 201.49M |
| SI-BONE | 200.93M |
| NeuroPace | 99.99M |
AVNS News
- 7 days ago - Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference - PRNewsWire
- 11 days ago - Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors - PRNewsWire
- 13 days ago - Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results - PRNewsWire
- 21 days ago - Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 4 weeks ago - CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026 - PRNewsWire
- 6 weeks ago - Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management - PRNewsWire
- 7 weeks ago - Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha